🤓 Just 1 week into 2025: These 7 AI-picked stocks are up 9%+ eachUnlock Stocks

Stocks rest after vaccine progress, dollar stuck at two-and-a-half-year low

Published 12/01/2020, 07:06 PM
Updated 12/02/2020, 05:00 AM
© Reuters. People wearing protective face masks, following an outbreak of the coronavirus, are reflected on a screen showing Nikkei index, outside a brokerage in Tokyo

© Reuters. People wearing protective face masks, following an outbreak of the coronavirus, are reflected on a screen showing Nikkei index, outside a brokerage in Tokyo

UK100
-0.12%
AMZN
0.01%
PFE
-1.00%
DE30
-0.11%
LCO
2.16%
CL
2.18%
EU50
-0.12%
US10YT=X
0.28%
META
-1.16%
USO
-1.11%
SFTBY
1.24%
MRNA
-9.17%
BNTX
-3.73%

By Carolyn Cohn

LONDON (Reuters) - World stocks hovered near record highs on Wednesday on hopes for a coronavirus vaccine and additional U.S. economic stimulus, though enthusiasm for riskier assets left the dollar stuck at a 2-1/2 year low.

Britain on Wednesday became the first country in the world to approve the Pfizer-BioNTech COVID-19 vaccine for use, saying it would start rolling it out early next week.

The two drug firms and competitor Moderna (NASDAQ:MRNA) have also sought emergency use approval from European regulators this week.

Top U.S. health officials have announced plans to start vaccinating Americans as early as mid-December once regulatory approvals are in place. Nationwide deaths hit 2,295 on Monday the highest toll in six months.

"Approval of a highly effective vaccine may mark the beginning of the end to the COVID-19 economic turmoil and the beginning of a new bull market for equities," said Mike Bell, global market strategist at J.P. Morgan Asset Management.

"The scientists have come to the rescue and delivered what investors were hoping for Christmas."

Despite the positive news, European stocks struggled to add to their recent surge in early trading but MSCI's gauge of stocks across the globe inched up 0.1% to keep it near an all-time high.

The dollar was stuck at 2-1/2 year lows against the euro and an index of major currencies as investors sought out the higher risk currencies that had fallen during the earlier stages of the pandemic.

Yields on euro zone government bonds edged up to their highest in three weeks at -0.51%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads.

Pfizer (NYSE:PFE) and BioNTech said their vaccine could be launched in the European Union as early as this month, though a European regulator clouded the schedule when it said it would complete its review of their vaccine by Dec. 29.

Deutsche Bank (DE:DBKGn) analysts said the early approval and roll-out of the vaccine in Britain "raises the prospect that life could return closer to normal early next year".

Shares in BioNTech surged by more than 8% before trimming gains, though European shares slipped overall by 0.3%, shuffling below recent nine-month highs.

HOT OIL

Markets were also hoping for more fiscal relief. Top U.S. Senate Republican Mitch McConnell said on Tuesday that Congress should include new coronavirus stimulus in a $1.4 trillion spending bill aimed at heading off a government shutdown in the midst of the pandemic.

U.S. President-elect Joe Biden told the New York Times his priority is getting a generous aid package through Congress even before he takes office in January.

U.S. stock futures declined 0.23% following a record closing high for Wall Street shares.

The pound was under some pressure, however, as a senior EU diplomat said UK's post-Brexit trade deal with the European Union "still hangs in balance".

Sterling fell more than 0.5% to $1.3354. UK blue-chip stocks were steady.

In Asia, shares in China recovered from early losses and rose 0.12%.

Tokyo stocks were little changed after setting a new 29-year high. Softbank (OTC:SFTBY) Group shares fell 0.66% after Bloomberg News said the tech investor is winding down its options trades on companies including Amazon.com Inc (NASDAQ:AMZN) and Facebook Inc (NASDAQ:FB).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads.

Oil prices were also lifted by the vaccine optimism, reversing earlier losses made after OPEC and its allies left markets in limbo by postponing a formal meeting to decide whether to lift output in January.

Brent crude futures rose 0.15% to $47.49 per barrel, while U.S. crude was down 0.09% at $44.51 per barrel. Oil has raced up nearly 30% over the last month.

Should you invest $1,000 in AMZN right now?

Don't miss out on the next big opportunity! Stay ahead of the curve with ProPicks AI – 6 model portfolios powered by AI stock picks with a stellar performance in 2024.

Unlock ProPicks to find out

Latest comments

stephen outhwaiteDec 03, 2020, 14:21
looks like they're gonna do the full vaccine tests in Brexit Britain, wonder how much Boris got tickled for that?
stephen outhwaiteDec 03, 2020, 14:22
that'll be the LD 50 tests
Dietmar StahlDec 02, 2020, 18:46
Germany to keep restaurants and hotels closed to January 10 for now
Show all comments
Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.